Tuberculosis -

MMWR Booster for: Tuberculosis — United States, 2023 / Weekly / March 28, 2024 / 73(12);265–270

Posted on March 29, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways Increased TB Case Counts Across All Groups: In 2023, the U.S. saw an increase in tuberculosis (TB) cases across all age groups, U.S.-born and non-U.S.–born persons, and

MMWR Booster for: Tuberculosis Preventive Treatment Update — U.S. President’s Emergency Plan for AIDS Relief, 36 Countries, 2016–2023 / Weekly / March 21, 2024 / 73(11);233–238

Posted on March 22, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways Significant Scale-Up in TB Preventive Treatment: From October 2016 to October 2023, about 13 million ART clients completed Tuberculosis Preventive Treatment (TPT) across 36 countries supported by

MMWR Booster for: Notes from the Field: Supply Interruptions of First- and Second-Line Oral Drugs to Treat Tuberculosis During the Previous 12 Months — California, January–March, 2023. Weekly / January 5, 2024 / 72(5253);1390–1391

Posted on January 5, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways Recurrent Drug Shortages: The U.S., particularly California, has faced recurring shortages of first- and second-line TB drugs, impacting treatment regimens. High Priority Concern: California TB programs rated

MMWR Booster for: Second Nationwide Tuberculosis Outbreak Caused by Bone Allografts Containing Live Cells — United States, 2023, January 5, 2024 / 72(5253);1385–1389

Posted on January 5, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways Second Outbreak in Recent Years: This report covers the second outbreak of TB related to bone allografts in recent years, with 36 recipients affected. Initial Detection and

Epidemiology, Broadly Speaking

Tag: Tuberculosis